The US Food and Drug Administration has cancelled a crucial meeting with its Vaccines and Related Biological Products Advisory Committee, originally scheduled for March 13. This decision comes as concerns over the ongoing COVID-19 pandemic take precedence. The committee was set to recommend strains for the upcoming 2025-2026 flu vaccine, a process typically overseen by the FDA.
Source: https://insights.citeline.com/pink-sheet/vaccines/breaking-us-fda-cancels-upcoming-adcomm-discussing-2025-2026-flu-vaccine-AGBZQHYGZFHZLOK2PU5CCKBNK4